7.2 Ethics and Regulatory/Oversight Organizations

Key Takeaways

  • The four principles of biomedical ethics (Beauchamp and Childress) are autonomy, beneficence, nonmaleficence, and justice.
  • The APhA/ACPE Code of Ethics for Pharmacists establishes that a pharmacist's primary obligation is to the patient's welfare.
  • Informed consent requires disclosure of material risks, patient capacity, and voluntariness; pharmacists support prescribers in this process.
  • The FDA (CDER, CBER), DEA, state boards of pharmacy, and NABP have distinct, non-overlapping regulatory roles in US pharmacy.
  • ACPE accredits schools of pharmacy, ASHP accredits pharmacy residencies, and The Joint Commission accredits hospitals and health systems.
Last updated: July 2026

Biomedical Ethics: The Four-Principles Framework

The dominant framework in US health care ethics comes from Beauchamp and Childress's Principles of Biomedical Ethics. The four principles provide a shared vocabulary for clinical and organizational decisions.

PrincipleDefinitionPharmacy Application
AutonomyRespect for the patient's right to self-determinationHonor refusals of therapy, informed consent, advance directives
BeneficenceAct in the patient's best interestRecommend optimal therapy, conduct MTM interventions
NonmaleficenceDo no harmVerify doses, screen for interactions, prevent dispensing errors
JusticeFair distribution of benefits and burdensEquitable allocation of scarce drugs, nondiscriminatory service

Code of Ethics for Pharmacists

The Code of Ethics for Pharmacists, jointly supported by APhA and ACPE, states that a pharmacist:

  • Respects the covenantal relationship with the patient.
  • Promotes the good of every patient in a caring, compassionate manner.
  • Respects the autonomy and dignity of each patient.
  • Acts with honesty and integrity in professional relationships.
  • Maintains professional competence.
  • Respects the values and abilities of colleagues and other health professionals.
  • Serves individual, community, and societal needs.
  • Seeks justice in the distribution of health resources.

Informed Consent and Patient Rights

Informed consent requires three elements: (1) disclosure of material risks, benefits, and alternatives; (2) capacity — the patient can understand the information and make a decision; and (3) voluntariness — no coercion. Pharmacists support informed consent by counseling on side effects, interactions, and alternatives, and by flagging concerns to prescribers when patients have unanswered questions.

Patient rights under HIPAA include the right to access their PHI, request amendments, receive a Notice of Privacy Practices, and file complaints. ACA-related patient rights include nondiscrimination, choice of provider within network, and emergency access without prior authorization.

Ethical Dilemmas in Pharmacy

Conscientious Objection

A pharmacist may decline to dispense on moral or religious grounds (for example, emergency contraception or mifepristone), but ethical practice requires that the patient not be abandoned. The pharmacist must: (1) notify the employer in advance, (2) ensure the patient can obtain the medication from another source without delay, and (3) refer or transfer the prescription. State laws vary — some explicitly protect conscientious objection, others require dispensing.

End-of-Life Care

Pharmacists involved in palliative care and hospice manage opioids, anxiolytics, and sedatives ethically under the principle of double effect — providing adequate analgesia even if a foreseeable but unintended consequence is respiratory depression. Pharmacists also navigate requests for medical aid in dying under Death with Dignity laws in Oregon, Washington, California, and several other states.

Rationing and Off-Label Use

During drug shortages, pharmacists allocate scarce agents under justice principles — by clinical need, not by ability to pay or social worth. Off-label use is legal if supported by evidence; pharmacists verify the indication, dosing, and supporting literature, and inform patients when a use is off-label.

Regulatory Organizations

Federal Regulators

  • FDA (Food and Drug Administration) — Within the FDA, CDER (Center for Drug Evaluation and Research) regulates conventional drugs and some biologics, while CBER (Center for Biologics Evaluation and Research) regulates biologics, vaccines, blood products, and cell and gene therapies. The FDA oversees drug approval, labeling, REMS, post-marketing surveillance (MedWatch), and manufacturing quality.
  • DEA (Drug Enforcement Administration) — Enforces the CSA, registers pharmacies and prescribers, sets production quotas, and investigates diversion.

State Boards of Pharmacy

Each state has a Board of Pharmacy that licenses pharmacists, technicians, and pharmacies; inspects practice sites; enforces state practice acts; and takes disciplinary action. State boards administer the MPJE (Multistate Pharmacy Jurisprudence Examination) for licensure. State law may be more restrictive than federal law, but not less.

NABP (National Association of Boards of Pharmacy)

NABP is the association of state boards, not a regulator itself. Its programs include:

  • NAPLEX (North American Pharmacist Licensure Examination) — clinical competence for licensure.
  • MPJE — jurisprudence exam.
  • FPGEC (Foreign Pharmacy Graduate Examination Committee) — certifies internationally educated pharmacists, including the FPGEE.
  • PMP InterConnect — links state Prescription Drug Monitoring Programs (PDMPs) across state lines to detect controlled substance diversion.
  • VIPPS (Verified Internet Pharmacy Practice Sites) — accreditation for online pharmacies.
  • NABP e-Profile — continuing pharmacy education (CPE) tracking for pharmacists and technicians.
Loading diagram...
US Pharmacy Regulatory and Professional Organization Structure

Professional Organizations and Accreditation

Professional Organizations

  • APhA (American Pharmacists Association) — largest pharmacist membership organization; advocacy and the Code of Ethics.
  • ASHP (American Society of Health-System Pharmacists) — hospital and health-system pharmacy; residency accreditation.
  • ACCP (American College of Clinical Pharmacy) — clinical pharmacy practice and research.
  • AMCP (Academy of Managed Care Pharmacy) — managed care and PBM practice; formulary management resources.
  • NCPA (National Community Pharmacists Association) — independent community pharmacy advocacy.
  • ASCP (American Society of Consultant Pharmacists) — geriatric and long-term care pharmacy.
  • USP (US Pharmacopeial Convention) — sets compendial standards (USP-NF), including <795>, <797>, and <800>.

Accreditation

  • ACPE (Accreditation Council for Pharmacy Education) accredits schools of pharmacy (PharmD programs) and certifies continuing pharmacy education providers.
  • ASHP accredits pharmacy residency programs (PGY-1 general and PGY-2 specialized).
  • The Joint Commission accredits hospitals and health systems, with medication management standards that drive pharmacy operations and patient safety.

Distinguishing FDA, DEA, State Boards, and NABP

A common exam point is the non-overlapping scope of these bodies. The FDA regulates drug products (approval, labeling, manufacturing). The DEA regulates controlled substances and the registrants who handle them. State boards regulate the practice of pharmacy and the licenses of pharmacists, technicians, and pharmacies within the state. NABP is the coordinating association of state boards and administers licensure exams but does not directly license pharmacists. Knowing which body does what helps answer jurisprudence-style questions on the FPGEE and MPJE.

Test Your Knowledge

A pharmacist declines to dispense emergency contraception on moral grounds. According to ethical best practice, what is the pharmacist's obligation?

A
B
C
D
Test Your Knowledge

Which organization accredits US pharmacy residency programs (PGY-1 and PGY-2)?

A
B
C
D